GARY S. ROUBIN
Medical Practice in New York, NY
License number
DC MD18119
Issued Date
Sep 29, 1989
Expiration Date
Dec 31, 2002
Category
MEDICINE
Type
MEDICINE AND SURGERY
Address
Address
Floor 9, New York, NY 10021
Professional information
Dr. Gary S Roubin, New York NY - MD (Doctor of Medicine)
Specialties:
Interventional Cardiology
Address:
425 W 59Th St STE 9A, New York 10019
(212) 523-7200 (Phone), (212) 523-7250 (Fax)
(212) 523-7200 (Phone), (212) 523-7250 (Fax)
Languages:
English, Chinese, French, Russian, Spanish
Hospitals:
425 W 59Th St STE 9A, New York 10019
Flushing Hospital Medical Center
45th Ave And Parsons Blvd, Flushing 11355
Jamaica Hospital Medical Center
8900 Van Wyck Expy, Jamaica 11418
Lenox Hill Hospital
100 East 77Th St, New York 10075
Long Island Jewish Medical Center
270 76Th Ave, New Hyde Park 11040
North Shore University Hospital
300 Community Dr, Manhasset 11030
Flushing Hospital Medical Center
45th Ave And Parsons Blvd, Flushing 11355
Jamaica Hospital Medical Center
8900 Van Wyck Expy, Jamaica 11418
Lenox Hill Hospital
100 East 77Th St, New York 10075
Long Island Jewish Medical Center
270 76Th Ave, New Hyde Park 11040
North Shore University Hospital
300 Community Dr, Manhasset 11030
Education:
Medical School
University Of Queensland
Graduated: 1975
University Of Queensland
Graduated: 1975
Gary Roubin, New York NY
Work:
Lenox Hill Hospital
130 E 77Th St, New York, NY 10075 Lenox Hill Hospital
100 E 77Th St, New York, NY 10075
130 E 77Th St, New York, NY 10075 Lenox Hill Hospital
100 E 77Th St, New York, NY 10075
Apparatus And Method For Delivering Compounds To A Living Organism
US Patent:
6471979, Oct 29, 2002
Filed:
Aug 30, 2001
Appl. No.:
09/943648
Inventors:
Gishel New - New York NY
Jeffrey W. Moses - New York NY
Nicholas Kipshidze - New York NY
Gary S. Roubin - New York NY
Martin B. Leon - New York NY
Jeffrey W. Moses - New York NY
Nicholas Kipshidze - New York NY
Gary S. Roubin - New York NY
Martin B. Leon - New York NY
Assignee:
Estrogen Vascular Technology, LLC - New York NY
International Classification:
A61K 31565
US Classification:
424422, 424423, 514182, 514824, 623 142, 623 143, 604264, 604 93, 604915
Abstract:
A method of treating or preventing vascular disease in a living organism. The method includes delivering an effective amount of a composition including a sex hormone, anti-hormone, sex-hormone agonist, steroid-hormone inhibitor/antagonist (partial or full), selective estrogen receptor modulator (SERM), or a combination thereof, to an affected area of a living organism.
Delivery Catheter
US Patent:
6669716, Dec 30, 2003
Filed:
Sep 29, 2000
Appl. No.:
09/672014
Inventors:
Paul Gilson - County Galway, IE
Gary S. Roubin - New York NY
Gary S. Roubin - New York NY
Assignee:
Salviac Limited - Dublin
International Classification:
A61B 1700
US Classification:
623 111, 606108, 606198
Abstract:
A rapid exchange stent delivery catheter for delivery and deployment of a stent has a catheter shaft having a guidewire lumen defined by a passageway with an entrance and an exit. The stent is of a shape memory metallic alloy and is constrained by a sheath. The sheath has an elongate slot aligned with the guidewire lumen entrance so that a guidewire is not obstructed during movement of the sheath to deploy the stent. The sheath is pulled back linearly by a thumbscrew mechanism to deploy the stent.
Surgically Closing Percutaneously Punctures
US Patent:
2013017, Jul 11, 2013
Filed:
Sep 6, 2012
Appl. No.:
13/605720
Inventors:
Greg Walters - Exton PA, US
Gary Roubin - New York NY, US
Michael Nispel - Malvern PA, US
Mike Dotsey - , US
Piyush Arora - , US
Gary Roubin - New York NY, US
Michael Nispel - Malvern PA, US
Mike Dotsey - , US
Piyush Arora - , US
Assignee:
ESSENTIAL MEDICAL, LLC - Wayne PA
International Classification:
A61B 17/00
US Classification:
606213
Abstract:
A closure device for sealing a percutaneous puncture in a wall of a body passageway, the closure device including at least one of a toggle configured to engage an interior surface of the body passageway or a plug configured to engage an exterior surface of the body passageway and a guide wire configured to extend from an outside of the body to inside the body passageway, wherein at least one of the toggle and the plug is associated with the guide wire.
Methods And Devices For Using Drug-Eluting Embolization
US Patent:
2008008, Apr 10, 2008
Filed:
May 7, 2007
Appl. No.:
11/745203
Inventors:
Robert Rosen - New York NY, US
Nicholas Kipshidze - New York NY, US
Sriram Iyer - New York NY, US
Gary Roubin - New York NY, US
Nicholas Kipshidze - New York NY, US
Sriram Iyer - New York NY, US
Gary Roubin - New York NY, US
International Classification:
A61B 17/03
US Classification:
606158000
Abstract:
A method and system of embolizing an organ or vessel is disclosed. An embolization device such as a coil, balloon, spheres, stents or occlusive plaques is used. The embolization device has a surface, which may be coated with composition retaining material such as a polymer, bio-polymer or non-polymer based technology that allows sustained release of drug or material from drug eluting occlusive device. For example, an anti-angiogenic composition is coated on the application surface. The embolization device is then inserted in the vessel and embolization is enhanced by the composition.
Apparatus And Method For Delivering Compounds To A Living Organism
US Patent:
2003003, Feb 27, 2003
Filed:
Sep 30, 2002
Appl. No.:
10/260954
Inventors:
Gishel New - New York NY, US
Jeffrey Moses - New York NY, US
Nicholas Kipshidze - New York NY, US
Gary Roubin - New York NY, US
Martin Leon - New York NY, US
Jeffrey Moses - New York NY, US
Nicholas Kipshidze - New York NY, US
Gary Roubin - New York NY, US
Martin Leon - New York NY, US
Assignee:
ESTROGEN VASCULAR TECHNOLOGY, LLC.
International Classification:
A61K031/56, A61F002/00
US Classification:
424/423000, 514/182000, 514/178000
Abstract:
A method of treating or preventing vascular disease in a living organism. The method includes delivering an effective amount of a composition including a sex hormone, anti-hormone, sex-hormone agonist, steroid-hormone inhibitor/antagonist (partial or full), selective estrogen receptor modulator (SERM), or a combination thereof, to an affected area of a living organism.
Bifurcated Catheter
US Patent:
2013033, Dec 12, 2013
Filed:
Jun 10, 2013
Appl. No.:
13/914430
Inventors:
Gary Roubin - New York NY, US
International Classification:
A61N 1/05
US Classification:
607122
Abstract:
Systems and methods are disclosed for a bifurcated catheter, and more particularly, to denervation of arterial nerves using a bifurcated catheter. In embodiments, the catheter comprises, for example, a catheter shaft bifurcated into a first catheter energy member and a second catheter energy member, wherein the first catheter energy member comprises a first transducer and the second catheter energy member comprises a second transducer, and wherein the first and second transducers are configured to cause denervation of an arterial nerve of the patient.